Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis Jean-Frédéric Colombel,

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

MiraLAX Is Not as Effective as GoLytely in Bowel Cleansing Before Screening Colonoscopies Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen.

Volume 137, Issue 4, Pages (October 2009)

The Role of Psychosocial Care in Adapting to Health Care Reform

Abnormal Liver Tests and Fatty Liver on Ultrasound

Guillaume Bouguen, Barrett G. Levesque, Brian G

Saurabh Dawra, Vishal Sharma, Usha Dutta

Issue Highlights Clinical Gastroenterology and Hepatology

Certolizumab Pegol in Patients With Moderate to Severe Crohn's Disease and Secondary Failure to Infliximab William J. Sandborn, Maria T. Abreu, Geert.

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure Stephen J.D. O'Keefe, Palle B. Jeppesen,

Volume 135, Issue 4, Pages (October 2008)

Efficacy of Topical 5-Aminosalicylates in Preventing Relapse of Quiescent Ulcerative Colitis: A Meta-analysis Alexander C. Ford, Khurram J. Khan, William.

Pichamol Jirapinyo, Christopher C. Thompson

Heterogeneity in Definitions of Endpoints for Clinical Trials of Ulcerative Colitis: A Systematic Review for Development of a Core Outcome Set Christopher.

Safety and Efficacy of Teduglutide After 52 Weeks of Treatment in Patients With Short Bowel Intestinal Failure Stephen J.D. O'Keefe, Palle B. Jeppesen,

Shou–Jiang Tang, Feriyl Bhaijee

Katsunori Matsueda, Tatsuya Toyokawa

A Shocking Cystory Clinical Gastroenterology and Hepatology

Volume 133, Issue 1, Pages (July 2007)

Immune Reconstitution Inflammatory Syndrome of the Small Bowel in a Human Immunodeficiency Virus–Negative Patient Severin Daum, Christoph Loddenkemper,

Laurent Peyrin-Biroulet, Julián Panés, William J

Association Between Plasma Concentrations of Certolizumab Pegol and Endoscopic Outcomes of Patients With Crohn's Disease Jean–Frédéric Colombel, William.

Association of Trough Serum Infliximab to Clinical Outcome After Scheduled Maintenance Treatment for Crohn’s Disease Elana A. Maser, Renata Villela,

Jessica L. Mellinger, Michael L. Volk

Patrick B. Allen, Paul J. Kettle, Inder Mainie

Volume 130, Issue 2, Pages (February 2006)

Activity-Based Costing and Management in a Hospital-Based GI Unit

Volume 147, Issue 3, Pages e3 (September 2014)

Endoscopic Therapy for Barrett's Esophagus

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Dysphagia Caused by Extrinsic Esophageal Compression From Mediastinal Lymphadenopathy in Patients With Sarcoidosis Faisal Inayat, Qulsoom Hussain, Khurram.

Volume 146, Issue 1, Pages e1 (January 2014)

Obstructive Jaundice Caused by Intraductal Hepatocellular Carcinoma

Rapid Disappearance of a Pancreatic Cyst After Steroid Therapy in a Patient With Autoimmune Pancreatitis Terumi Kamisawa, Hajime Anjiki, Naoto Egawa

A Test-based Strategy Is More Cost Effective Than Empiric Dose Escalation for Patients With Crohn's Disease Who Lose Responsiveness to Infliximab Fernando.

Abnormal Liver Tests and Fatty Liver on Ultrasound

Thurarshen Jeyalingam, Yuto Shimamura, Christopher Teshima

Gastroenterology in a New Era of Accountability: Part 2

Volume 137, Issue 4, Pages (October 2009)

Volume 147, Issue 6, Pages e5 (December 2014)

New Models of Gastroenterology Practice

William J. Sandborn, Stefan Schreiber, Brian G

Volume 145, Issue 5, Pages e5 (November 2013)

Volume 154, Issue 6, Pages (May 2018)

Volume 132, Issue 1, Pages (January 2007)

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

David H. Bruining, William J. Sandborn

Mucosal Healing Is Associated With Improved Long-term Outcomes of Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis Shailja C.

Association Between Pharmacokinetics of Adalimumab and Mucosal Healing in Patients With Inflammatory Bowel Diseases Xavier Roblin, Hubert Marotte, Melanie.

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Correlation Between the Crohn's Disease Activity and Harvey–Bradshaw Indices in Assessing Crohn's Disease Severity Severine Vermeire, Stefan Schreiber,

Reinduction With Certolizumab Pegol in Patients With Relapsed Crohn's Disease: Results From the PRECiSE 4 Study William J. Sandborn, Stefan Schreiber,

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Walter Reinisch, Jean-Frederic Colombel, William J

Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trial Paul Rutgeerts, MD,

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Patrick Yachimski, William P. Puricelli, Norman S. Nishioka

Volume 142, Issue 2, Pages e3 (February 2012)

Coagulation in Liver Disease: A Guide for the Clinician

Issue Highlights Clinical Gastroenterology and Hepatology

Issue Highlights Clinical Gastroenterology and Hepatology

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

Medical Therapy for Refractory Pediatric Crohn’s Disease

M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu

Issue Highlights Clinical Gastroenterology and Hepatology

Rintaro Hashimoto, Akimichi Chonan

The Role of Psychosocial Care in Adapting to Health Care Reform

Choosing Wisely and the Perceived Drivers of Endoscopy Use

Presentation transcript:

Combination Therapy With Infliximab and Azathioprine Improves Infliximab Pharmacokinetic Features and Efficacy: A Post Hoc Analysis Jean-Frédéric Colombel, Omoniyi J. Adedokun, Christopher Gasink, Long-Long Gao, Freddy J. Cornillie, Geert R. D'Haens, Paul J. Rutgeerts, Walter Reinisch, William J. Sandborn, Stephen B. Hanauer Clinical Gastroenterology and Hepatology Volume 17, Issue 8, Pages 1525-1532.e1 (July 2019) DOI: 10.1016/j.cgh.2018.09.033 Copyright © 2019 AGA Institute Terms and Conditions

Figure 3 Proportions of patients achieving corticosteroid-free remission at week 34 (CSFR34) by serum trough infliximab concentration at week 30. Q, quartile. Clinical Gastroenterology and Hepatology 2019 17, 1525-1532.e1DOI: (10.1016/j.cgh.2018.09.033) Copyright © 2019 AGA Institute Terms and Conditions